This includes 14.3 million views on YouTube and 9.8 million views on Meta platforms to amplify preventive heart health message
The JADE trial enrolled 164 U.S. patients who initially received three monthly doses of OLN324 or faricimab, followed by 12 weeks off treatment with retreatment allowed only if disease recurred
UBT251 appeared to have a safe and well-tolerated profile consistent with incretin-based therapies
The company said it received notice on January 1 from the FDA’s Center for Veterinary Medicine that the funding will support its ongoing effectiveness study of Canalevia-CA1
India’s traditional medicine systems have also earned formal recognition in key bilateral trade agreements
The company also reported significant progress toward its internally defined Sustainable Development Goals
Patients on baxdrostat showed a significant reduction in systolic blood pressure (SBP) compared to placebo
Novartis India has reported total income of Rs. 99.73 crore during the period ended September 30, 2025
Sanofi Ventures drives innovation through leading and participating in private financing rounds for pioneering healthcare companies
Subscribe To Our Newsletter & Stay Updated
